- Home
- APRE vs PMNT Comparison
APRE vs PMNT Comparison
Compare APRE & PMNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- PMNT
- Stock Information
- Founded
- APRE 2006
- PMNT 1984
- Country
- APRE United States
- PMNT United Kingdom
- Employees
- APRE N/A
- PMNT N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- PMNT
- Sector
- APRE Health Care
- PMNT
- Exchange
- APRE Nasdaq
- PMNT NYSE
- Market Cap
- APRE 15.8M
- PMNT 14.6M
- IPO Year
- APRE 2019
- PMNT 2024
- Fundamental
- Price
- APRE $3.05
- PMNT $1.19
- Analyst Decision
- APRE Strong Buy
- PMNT Strong Buy
- Analyst Count
- APRE 2
- PMNT 1
- Target Price
- APRE $15.50
- PMNT $6.00
- AVG Volume (30 Days)
- APRE 22.6K
- PMNT 87.3K
- Earning Date
- APRE 11-07-2024
- PMNT 11-14-2024
- Dividend Yield
- APRE N/A
- PMNT N/A
- EPS Growth
- APRE N/A
- PMNT N/A
- EPS
- APRE N/A
- PMNT N/A
- Revenue
- APRE $1,310,839.00
- PMNT $22,375,000.00
- Revenue This Year
- APRE $134.21
- PMNT $3.91
- Revenue Next Year
- APRE N/A
- PMNT $29.32
- P/E Ratio
- APRE N/A
- PMNT N/A
- Revenue Growth
- APRE 130.31
- PMNT N/A
- 52 Week Low
- APRE $2.15
- PMNT $0.70
- 52 Week High
- APRE $8.85
- PMNT $6.05
- Technical
- Relative Strength Index (RSI)
- APRE 43.20
- PMNT N/A
- Support Level
- APRE $3.02
- PMNT N/A
- Resistance Level
- APRE $3.39
- PMNT N/A
- Average True Range (ATR)
- APRE 0.30
- PMNT 0.00
- MACD
- APRE -0.01
- PMNT 0.00
- Stochastic Oscillator
- APRE 3.85
- PMNT 0.00
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.